These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34538691)
21. Barriers to Buprenorphine Prescribing Among Attending Physicians in an Academic Residency Program - Implications for Increased Buprenorphine Usage. van Deventer E; Antonson D; Soske J; Geary M; Vanjani R R I Med J (2013); 2023 Oct; 106(9):31-35. PubMed ID: 37768160 [TBL] [Abstract][Full Text] [Related]
22. Buprenorphine Provision by Early Career Family Physicians. Tong ST; Hochheimer CJ; Peterson LE; Krist AH Ann Fam Med; 2018 Sep; 16(5):443-446. PubMed ID: 30201642 [TBL] [Abstract][Full Text] [Related]
24. Practice Predictors of Buprenorphine Prescribing by Family Physicians. Peterson LE; Morgan ZJ; Borders TF J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252 [TBL] [Abstract][Full Text] [Related]
25. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. Wen H; Hockenberry JM; Pollack HA JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185 [TBL] [Abstract][Full Text] [Related]
26. Why aren't physicians prescribing more buprenorphine? Huhn AS; Dunn KE J Subst Abuse Treat; 2017 Jul; 78():1-7. PubMed ID: 28554597 [TBL] [Abstract][Full Text] [Related]
27. Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. Jawa R; Walley AY; Wilson DJ; Green TC; McKenzie M; Hoskinson R; Bratberg J; Ramsey S; Rich JD; Friedmann PD J Acquir Immune Defic Syndr; 2022 Aug; 90(5):546-552. PubMed ID: 35587832 [TBL] [Abstract][Full Text] [Related]
28. Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder. McCollum CG; Eaton E; Creger T; Lee A; Gagnon K; Li L Drug Alcohol Depend; 2023 Mar; 244():109777. PubMed ID: 36680808 [TBL] [Abstract][Full Text] [Related]
29. Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings. Wilson JD; Spicyn N; Matson P; Alvanzo A; Feldman L Subst Abus; 2016; 37(3):480-487. PubMed ID: 26820604 [TBL] [Abstract][Full Text] [Related]
30. Preliminary results of the evaluation of the California Hub and Spoke Program. Darfler K; Sandoval J; Pearce Antonini V; Urada D J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985 [TBL] [Abstract][Full Text] [Related]
31. Buprenorphine prescribing practice trends and attitudes among New York providers. Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Pytell JD; Buresh ME; Graddy R Addict Sci Clin Pract; 2019 Dec; 14(1):46. PubMed ID: 31856915 [TBL] [Abstract][Full Text] [Related]
33. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients. Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241 [TBL] [Abstract][Full Text] [Related]
35. Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care. Krupp J; Hung F; LaChapelle T; Yarrington ME; Link K; Choi Y; Chen H; Marais AD; Sachdeva N; Chakraborty H; McKellar MS South Med J; 2023 Apr; 116(4):333-340. PubMed ID: 37011580 [TBL] [Abstract][Full Text] [Related]
36. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers. Knudsen HK; Lofwall MR; Walsh SL; Havens JR; Studts JL J Addict Med; 2018; 12(1):31-39. PubMed ID: 28914663 [TBL] [Abstract][Full Text] [Related]
37. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine. Andrilla CHA; Jones KC; Patterson DG J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634 [TBL] [Abstract][Full Text] [Related]
38. Get Waivered: A Resident-Driven Campaign to Address the Opioid Overdose Crisis. Martin A; Kunzler N; Nakagawa J; Lee B; Wakeman S; Weiner S; Raja AS Ann Emerg Med; 2019 Nov; 74(5):691-696. PubMed ID: 31272821 [No Abstract] [Full Text] [Related]
39. Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder. Solmeyer AR; Berger AT; Barton SL; Nguyen B; Bart GB; Grahan B; Bell HJ; DeVine KM; Merrick W JAMA Health Forum; 2022 Nov; 3(11):e224149. PubMed ID: 36399352 [TBL] [Abstract][Full Text] [Related]
40. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. LaBelle CT; Han SC; Bergeron A; Samet JH J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]